Vito GUAGNANO

FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS

FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS

FGFR inhibitor for use in the treatment of hypophosphatemic disorders

Imidazopyrrolidine derivatives and their use in the treatment of disease

Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of disease

N-Oxide of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1--1-methyl-urea

Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease

PYRAZOLOPYRROLIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE

Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the P53/MDM2 interaction

Substituted purinone compounds

METHODS OF MONITORING THE MODULATION OF THE KINASE ACTIVITY OF FIBROBLAST GROWTH FACTOR RECEPTOR AND USES OF SAID METHODS

N-Oxide of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1--1-methyl-urea

Pyrazolopyrrolidine compounds

Pyrazolopyrrolidine derivatives and their use in the treatment of disease

IMIDAZOPYRROLIDINONE COMPOUNDS

Cyclohexyl isoquinolinone compounds

PYRROLIDINE-1,2-DICARBOXAMIDE DERIVATIVES

Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseases

Pyrrolidine-1,2-dicarboxamide derivatives

Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors

Pyrrolopyrrolidinone compounds

Pyrirnidinyl aryl urea derivatives being FGF inhibitors

COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS

COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS

METHOD OF IDENTIFICATION OF CELLS THAT SHOW SENSITIVITY TO MODULATION OF SIGNALING MEDIATED BY A FIBROBLAST GROWTH FACTOR RECEPTOR OR A VARIANT THEREOF

Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors

Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors

Pyrrolidine-1,2-dicarboxamide derivatives

METHOD FOR TREATING HAEMATOLOGICAL CANCERS

N-Oxide of 3-(2,6-dichloro-3,5-dimethoxy-phenyl) -1--1-methyl-urea

PHENYLACETAMIDES SUITABLE AS PROTEIN KINASE INHIBITORS

ETHER DERIVATIVES OF BICYCLIC HETEROARYLS

METHODS OF MONITORING THE MODULATION OF THE KINASE ACTIVITY OF FIBROBLAST GROWTH FACTOR RECEPTOR AND USES OF SAID METHOD

METHOD OF TREATING DISORDERS MEDIATED BY THE FIBROBLAST GROWTH FACTOR RECEPTOR

Pyrrolidine-1,2-dicarboxamide derivatives

Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors

Phenylacetamides being FLT3 inhibitors

METHOD OF IDENTIFICATION OF CELLS THAT SHOW SENSITIVITY TO MODULATION OF SIGNALINGH MEDIATED BY FIBROBLAST GROWTH FACTOR RECEPTOR OR A VARIANT THEREOF

DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS

Organic compounds

Compounds and compositions as protein kinase inhibitors

Method of Treating Disorders Mediated by the Fibroblast Growth Factor Receptor

Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors

Phenylacetamides suitable as protein kinase inhibitors

Pyrimidinyl aryl urea derivatives being FGF inhibitors

Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases

Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors

DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS

Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors

Thiazole and pyrazole derivatives as Flt-3 kinase inhibitors

Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors

Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases

2-{[N-(2-amino-3-(heteroaryl or aryl) propionyl)-aminoacyl]-amino}-alkylboronic acid derivatives

2-{N-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl}-amino}-alkylboronic acid derivatives